🦊/Investors

Cadence Healthcare VenturesFull Portfolio

7 tracked investments · listed companies and verified rows first

Alleviant Medical Incalleviantmedical.comin𝕏Dec 2024SEC filingmedium confidence

Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).

BiotechHealthtechMedical DevicesAustin, US

Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)

BoardGeoff Pardo(Director)in

Board seatChristopher Kaster· per SEC Form D · $91.4M raise · filed Jan 2025

Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundGilde HealthcareGilmartin Capital LLCS3 Ventures+1 more

SetPoint Medicalsetpointmedical.comin𝕏Aug 2015SEC filingmedium confidence

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in

BoardBlake Wu(Director)inJuan-Pablo Mas(Director)in

Board seatChristopher Kaster· per SEC Form D · $15.1M raise · filed Sep 2015

Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCatalio Capital Management, LPCitta Capital+5 more

Koya Medicalkoyamedical.cominFeb 2022 · $26M

Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.

HardwareHealthtechMedical DevicesOakland, US

Anand Doraiswamy(Executive Officer, Director)in

BoardJosh Baltzell(Director)inJan Garfinkle(Director)in

Co-investorsAphelion CapitalArboretum VenturesScientific Health DevelopmentZühlke VenturesOrbiMed

Venova Medicalvenovamedical.cominSep 2024

Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.

HealthtechMedical DevicesLos Gatos, US

Erik van der Burg(Executive Officer, Director)in

BoardMichael Wallace(Director)inDarshana Zaveri(Director)inShant Vartanian(Director)in

Co-investorsAphelion CapitalShangBay Capital LLCCatalyst Health Ventures

Versa Vascularversavascular.cominDec 2025 · $27.3M

Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.

HealthtechMedical DevicesSanta Cruz, US

Co-investorsSanta Cruz VentureView VenturesBioStar CapitalS3 Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Iowa ApproachMVRx

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.